Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia

作者: Godfried H. J. Boers , Frans J. M. Trijbels , Diana G. Franken , Erik M. B. Stevens , Henk J. Blom

DOI:

关键词:

摘要: Summary Thermolability of 5,10-methylenetetrahydrofolate reduc­ tase (MTHFR) was examined as a possible cause mild hyperhomocysteinemia in patients with premature vascu­ lar disease. Control subjects and vascular normohomocysteinemia were studied. The mean (±SD) specific MTHFR activity lymphocytes 22 control 15.6 (±4.7) nmol CH20 /m g protein/h (range: 9.1-26,6), the residual after heat inactivation for 5 min at 46°C 55.3 (±12.0)% 35.9-78.3). By measurement activity, two distinct subgroups hyperhomocysteinemic became evident. One group (n - 11) had thermolabile 8.7 (±2.1) pro­ tein/h 5.5 -12.7) inactivation, ranging from 0% to 33%. other = 28) normal 21.5 (±7.2) 10.0-39.0) nor­ mal 53.8 (±9.2)% 33.171.5) ac­ tivity 29 normohomocysteinemic 20.7 (±6.5) 9.4-33.8), 58.2 (±10.2)% 43.0-82.0). Thus, 28% disease, abnormal homocysteine metabolism could be at­ tributed MTHFR.

参考文章(22)
V A McKusick, M Feinleib, H L Levy, R Havlik, S H Mudd, A study of cardiovascular risk in heterozygotes for homocystinuria. American Journal of Human Genetics. ,vol. 33, pp. 883- 893 ,(1981)
G Strokosch, J Zhou, P W Wong, S S Kang, J Kowalisyn, Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. American Journal of Human Genetics. ,vol. 43, pp. 414- 421 ,(1988)
Brian Fowler, Jan Kraus, Seymour Packman, Leon E. Rosenberg, Homocystinuria Journal of Clinical Investigation. ,vol. 61, pp. 645- 653 ,(1978) , 10.1172/JCI108976
M. Norusis, J. Sora, N. Ruggie, Soo-Sang Kang, P. W. K. Wong, A. Susmano, Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. American Journal of Human Genetics. ,vol. 48, pp. 536- 545 ,(1991)
P W Wong, A Horwitz, H G Bock, S S Kang, A Grix, Intermediate hyperhomocysteinemia resulting from compound heterozygosity of methylenetetrahydrofolate reductase mutations. American Journal of Human Genetics. ,vol. 48, pp. 546- 551 ,(1991)
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
Jean-Paul Harpey, David S. Rosenblatt, Bernard A. Cooper, Gisèle Le Moël, Claude Roy, Jacques Lafourcade, Homocystinuria caused by 5,10-methylenetetrahydrofolate reductase deficiency: A case in an infant responding to methionine, folinic acid, pyridoxine, and vitamin B12 therapy The Journal of Pediatrics. ,vol. 98, pp. 275- 278 ,(1981) , 10.1016/S0022-3476(81)80660-9
L. Daly, K. Robinson, K.S. Tan, I.M. Graham, Hyperhomocysteinaemia: a metabolic risk factor for coronary heart disease determined by both genetic and environmental influences? QJM: An International Journal of Medicine. ,vol. 86, pp. 685- 689 ,(1993) , 10.1093/QJMED/86.10.685
H.J. Blom, E.F. van der Molen, Pathobiochemical implications of hyperhomocysteinemia Fibrinolysis and Proteolysis. ,vol. 8, pp. 86- 87 ,(1994) , 10.1016/0268-9499(94)90257-7